AGM
BNGO icon

Alpine Global Management’s Bionano Genomics BNGO Stock Holding History

Alpine Global Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-91
Closed -$80K – 183
2022
Q4 		$80K Buy
91
+64
+237% +$80.5K 0.03% 357
2022
Q3 		$29K Hold
27
– – 0.01% 156
2022
Q2 		$22K Hold
27
– – 0.01% 192
2022
Q1 		$41 Sell
27
-23
-46% -$31K 0.01% 319
2021
Q4 		$89K Buy
+50
New +$134K 0.01% 683

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpine Global Management's BNGO Position: Q1 2023 in Review

Alpine Global Management sold out of Bionano Genomics (BNGO) in Q1 2023, closing a stake of 91 shares — an estimated $80K sold.

Alpine Global Management first reported a position in BNGO in Q4 2021 and held it in 5 quarters. The position peaked at $89K in Q4 2021. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • Alpine Global Management reported no remaining Bionano Genomics position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 91 Bionano Genomics shares in Q1 2023, an estimated $80K.
  • Alpine Global Management first reported a position in Bionano Genomics in Q4 2021 and held it in 5 quarters.
  • Alpine Global Management's Bionano Genomics position peaked at $89K in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.